Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 19/20 | 0.66 |
| ▸ | HDAC3 | O15379 | 17/20 | 0.66 |
| ▸ | HDAC4 | P56524 | 17/20 | 0.66 |
| ▸ | HDAC1 | Q13547 | 17/20 | 0.66 |
| ▸ | HDAC7 | Q8WUI4 | 17/20 | 0.66 |
| ▸ | HDAC2 | Q92769 | 17/20 | 0.66 |
| ▸ | HDAC10 | Q969S8 | 17/20 | 0.66 |
| ▸ | HDAC11 | Q96DB2 | 17/20 | 0.66 |
| ▸ | HDAC8 | Q9BY41 | 17/20 | 0.66 |
| ▸ | HDAC9 | Q9UKV0 | 17/20 | 0.66 |
| ▸ | HDAC5 | Q9UQL6 | 17/20 | 0.66 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.49 |
| ▸ | KDM1A | O60341 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10194641 | 0.90 | HDAC6 (0.69) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL10194583 | 0.87 | HDAC3 (0.49) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL10194643 | 0.86 | HDAC6 (0.73) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL10194642 | 0.85 | HDAC6 (0.65) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL10194451 | 0.84 | HDAC6 (0.72) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL12933264 | 0.83 | HDAC6 (0.61) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL12933261 | 0.82 | HDAC6 (0.70) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL23055051 | 0.82 | HDAC6 (0.60) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL18407549 | 0.82 | HDAC6 (0.60) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL8250443 | 0.81 | HDAC3 (0.81) | HDAC6HDAC3HDAC4HDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8513237-B2 | Sulfonylamino-derivatives as novel inhibitors of histone deacetylase | JANSSEN PHARMACEUTICA N.V. (BE) | 2013-08-20 | — | — | US | disclosed |
| US-8513237-B2 | Sulfonylamino-derivatives as novel inhibitors of histone deacetylase | JANSSEN PHARMACEUTICA N.V. (BE) | 2013-08-20 | — | — | US | disclosed |
| US-20120178741-A1 | Sulfonylamino-Derivatives As Novel Inhibitors Of Histone Deacetylase | JANSSEN PHARMACEUTICA N.V. (BE) | 2012-07-12 | — | — | US | disclosed |
| US-20120178741-A1 | Sulfonylamino-Derivatives As Novel Inhibitors Of Histone Deacetylase | JANSSEN PHARMACEUTICA N.V. (BE) | 2012-07-12 | — | — | US | disclosed |
| US-8163733-B2 | Sulfonylamino-derivatives as novel inhibitors of histone deacetylase | JANSSEN PHARMACEUTICA N.V. (BE) | 2012-04-24 | — | — | US | disclosed |
| US-8163733-B2 | Sulfonylamino-derivatives as novel inhibitors of histone deacetylase | JANSSEN PHARMACEUTICA N.V. (BE) | 2012-04-24 | — | — | US | disclosed |
| US-7868205-B2 | Inhibitors of histone deacetylase | METHYLGENE INC. (CA) | 2011-01-11 | — | — | US | disclosed |
| US-7868205-B2 | Inhibitors of histone deacetylase | METHYLGENE INC. (CA) | 2011-01-11 | — | — | US | disclosed |
| US-20100234353-A1 | SULFONYLAMINO-DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-09-16 | — | — | US | disclosed |
| US-20100234353-A1 | SULFONYLAMINO-DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-09-16 | — | — | US | disclosed |
| US-7767679-B2 | Sulfonylamino-derivatives as novel inhibitors of histone deacetylase | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-08-03 | — | — | US | disclosed |
| US-7767679-B2 | Sulfonylamino-derivatives as novel inhibitors of histone deacetylase | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-08-03 | — | — | US | disclosed |
| US-20080132459-A1 | Inhibitors of Histone Deacetylase | METHYLGENE, INC. (CA) | 2008-06-05 | — | — | US | disclosed |
| US-20080132459-A1 | Inhibitors of Histone Deacetylase | METHYLGENE, INC. (CA) | 2008-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234353-A1 | SULFONYLAMINO-DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE | HDAC1, HDAC3, HDAC11 | HDAC6 11/4885HDAC3 2/4885HDAC4 8/4885 |
| US-20080132459-A1 | Inhibitors of Histone Deacetylase | HDAC1, HDAC5, HDAC3 | HDAC6 6/4885HDAC3 3/4885HDAC4 8/4885 |
| US-20120178741-A1 | Sulfonylamino-Derivatives As Novel Inhibitors Of Histone Deacetylase | HDAC1, HDAC3, HDAC11 | HDAC6 11/4885HDAC3 2/4885HDAC4 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.